Inhalable Drugs Let Patients Take a Breather from Needles
Earlier this month, a team of researchers led by the University of Colorado at Boulder announced that the inhalable measles vaccine they developed could lead to vaccines for other diseases.
Thomas King
[OneMedForum] Alexza Pharmaceuticals’ Pipeline Is Built for Speed
Alexza Pharmaceuticals of Mountain View, Calif., is focused on the development of inhalation drugs for the treatment of central nervous system disorders.
Alexza at the 2010 OneMedForum
Thomas King, President and CEO of Alexza Pharmaceuticals, discusses his company with William Dawson of LifeTech Capital, at the 2010 OneMedForum in San Francisco.